Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 28Lymphoma, Follicular 17Lymphoma, Non-Hodgkin 10Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Mantle-Cell 6Lymphoma 5Lymphoma, B-Cell, Marginal Zone 4Lymphoma, B-Cell 3Leukemia 3Neoplasms 2Bronchiolitis Obliterans Syndrome 2Tumor Lysis Syndrome 1Solid Tumors 1Recurrence 1Oncology Patients Receiving Chemotherapy 1Neoplasm, Residual 1Neoplasm Metastasis 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Lymphoid 1Leukemia, Hairy Cell 1Indolent Non-Hodgkin's Lymphoma 1Chromosome 17 deletion 1Carcinoma, Non-Small-Cell Lung 1B-cell Malignancies 1Anemia 1

Interventions

fludarabine phosphate 2Whole-Body Irradiation 2Mycophenolic Acid 2obinutuzumab 1letermovir 1carmustine, poliferprosan 20 drug combination 1Tacrolimus 1Stem Cell Transplantation 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Hematopoietic Stem Cell Transplantation 1Etoposide 1Cytarabine 1Cyclosporins 1Cyclosporine 1Cyclophosphamide 1Carmustine 16-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Prolymphocytic, B-Cell × obinutuzumab × Clear all
NCT03010358 2023-08-08

Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma

OHSU Knight Cancer Institute

Phase 1/2 Completed
24 enrolled 16 charts
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Leukemia, Hairy Cell, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Prolymphocytic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡